Many chemotherapeutic agents damage DNA, which is believed to mediate their therapeutic efficacy. However, most of these agents act pleiotropically and also damage RNA, raising questions about the con
Promising activity of BET protein inhibitors (BETis) is compromised by adaptive or innate resistance in AML. Here, modeling of BETi- persister/resistance (BETi-P/R) in human post-MPN secondary AML (s
A case study on acute lymphoblastic leukemia (ALL) cells. See the ranking of rapamycin in glucocorticoid resistance ALL cells. It proved that CDA does not heavily depend on the way of the signature ex
